Employees Retirement System of Texas - ISIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Employees Retirement System of Texas ownership history of ISIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$1,132,000
-52.0%
28,000
-31.7%
0.02%
-48.4%
Q2 2015$2,360,000
-19.4%
41,000
-10.9%
0.03%
-18.4%
Q1 2015$2,929,000
-38.4%
46,000
-40.3%
0.04%
-36.7%
Q4 2014$4,754,000
-14.4%
77,000
-46.2%
0.06%
-17.8%
Q3 2014$5,553,000
+12.7%
143,0000.0%0.07%
+15.9%
Q2 2014$4,926,000
+132.7%
143,000
+191.8%
0.06%
+125.0%
Q1 2014$2,117,000
+89.7%
49,000
+75.0%
0.03%
+100.0%
Q4 2013$1,116,00028,0000.01%
Other shareholders
ISIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
BB BIOTECH AG 6,634,838$268,180,0008.50%
DOWLING & YAHNKE LLC 676,379$27,339,0003.72%
WILLIAM HARRIS INVESTORS INC 317,301$12,826,0003.63%
Opus Point Partners Management, LLC 101,401$4,099,0002.26%
SOUND ENERGY PARTNERS, INC. 25,000$1,011,0002.04%
Sonora Investment Management, LLC 127,104$6,622,0002.00%
PINNACLE ASSOCIATES LTD 1,778,325$71,880,0001.59%
MESSNER & SMITH THEME VALUE INVESTMENT MANAGEMENT LTD /CA/ 17,000$687,0001.36%
Apex Capital Management 1,019,618$41,213,0000.93%
PERKINS CAPITAL MANAGEMENT INC 20,350$823,0000.92%
View complete list of ISIS PHARMACEUTICALS INC shareholders